Form 4 for LLY Lilly (Eli)
Accepted 2024-11-05 00:00:00 ET · period of report 2024-11-01 · accession 0000059478-24-000253 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-05 | 2024-11-01 | LLY | Montarce Lucas | EVP, CFO | M - OptEx | $0.00 | +1,074 | 11.5K | +10% | $0 |
| D | 2024-11-05 | 2024-11-01 | LLY | Montarce Lucas | EVP, CFO | F - Tax | $818.93 | -467.20 | 11.1K | -4% | -$382.6K |
| D | 2024-11-05 | 2024-11-01 | LLY | Montarce Lucas | EVP, CFO | M - OptEx | $0.00 | -1,074 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-01 | M | A | 1,074 | $0.00 | 11,541 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-01 | F | D | 467.20 | $818.93 | 11,073.80 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-11-01 | M | D | 1,074 | $0.00 | 0 | D | — · 2024-11-01 to 2024-11-01 | 1,074 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |